Determination of bupropion and its main metabolite in rat plasma by LC-MS and its application to pharmacokinetics.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmazie

• Publication date

  2011-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 22312695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple and sensitive LC-ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates.

  2011cited by this paper
• Inhibition of Human CYP2B6-Catalyzed Bupropion Hydroxylation by Ginkgo biloba Extract: Effect of Terpene Trilactones and Flavonols

  2009cited by this paper
• An LC Method for the Determination of Bupropion and Its Main Metabolite, Hydroxybupropion in Human Plasma

  2009cited by this paper
• Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

  2008cited by this paper
• CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

  2008cited by this paper
• Cytochrome P450 Enzymes and Transporters Induced by Anti-Human Immunodeficiency Virus Protease Inhibitors in Human Hepatocytes: Implications for Predicting Clinical Drug Interactions

  2007cited by this paper
• HPLC assay for bupropion and its major metabolites in human plasma.

  2005cited by this paper
• Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.

  2004cited by this paper
• High-throughput liquid chromatography-tandem mass spectrometry determination of bupropion and its metabolites in human, mouse and rat plasma using a monolithic column.

  2004cited by this paper
• HPLC determination and pharmacokinetics of sustained-release bupropion tablets in dogs.

  2003cited by this paper
• Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors.

  2003cited by this paper
• Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation.

  2001cited by this paper
• Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.

  2000cited by this paper
• CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

  2000cited by this paper
• Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.

  1997cited by this paper
• A high-performance liquid chromatographic method for quantitating bupropion in human plasma or serum.

  1995cited by this paper
• Bupropion and alcohol fatal intoxication: case report.

  1992cited by this paper
• Tissue distribution of bupropion in a fatal overdose.

  1992cited by this paper
• Mass spectrometric investigation of 2-aminopropiophenones and some of their metabolites.

  1991cited by this paper
• Bupropion in depression. II. The role of metabolites in clinical outcome.

  1988cited by this paper
• Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection.

  1984cited by this paper
• Metabolism and kinetics of bupropion.

  1983cited by this paper

• An Integrated AI‐PBPK Platform for Predicting Drug In Vivo Fate and Tissue Distribution in Human and Inter‐Species Extrapolation

  2025influential citation
• Spectrofluorimetric method for determination of bupropion in pharmaceutical dosage forms.

  2019cites this paper
• Metabolism of liver CYP450 and ultrastructural changes after long-term administration of aspirin and ibuprofen.

  2018cites this paper
• Application of wavelet and Fuorier transforms as powerful alternatives for derivative spectrophotometry in analysis of binary mixtures: A comparative study.

  2018cites this paper
• Co‐Administration of Low‐Dose Naltrexone and Bupropion Reduces Alcohol Drinking in Alcohol‐Preferring (P) Rats

  2018cites this paper
• Simultaneous Quantitative Determination of Bupropion and its Metabolites by High Performance Liquid Chromatography Tandem Mass Spectrometry Detection: Application to Bioequivalence Study

  2018cites this paper
• Simultaneous determination of naltrexone and bupropion in their co-formulated tablet utilizing green chromatographic approach with application to human urine

  2017cites this paper
• Assessment of critical extraction and chromatographic parameters for the determination of bupropion and its three primary metabolites in human plasma by LC-MS/MS

  2017cites this paper
• Analytical Strategies for the Determination of Norepinephrine Reuptake Inhibitors in Pharmaceutical Formulations and Biological Fluids

  2016cites this paper
• Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet.

  2016cites this paper
• In vitro/in vivo evaluation of agar nanospheres for pulmonary delivery of bupropion HCl

  2015influential citation
• Simultaneous and sensitive analysis of fourth-generation antidepressants in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry

  2013cites this paper
• Liquid Chromatography Tandem mass spectrometry method forQuantification of Buproprion and Hydroxy Buproprion in HumanPlasma and its application to Bioequivalence Study

  2012cites this paper
• Liquid Chromatography Tandem mass spectrometry method for Quantification of Buproprion and Hydroxy Buproprion in Human Plasma and its application to Bioequivalence Study

  2012cites this paper